Related Experiment Videos
A new three-dimensional dose distribution reduction scheme for tubular organs
S M Zhou1, L B Marks, G S Tracton
1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA. zhou@radonc.duke.edu
Medical Physics
|September 13, 2000
Summary
A new method, dose-circumference-histograms (DCHs), captures spatial dose data in tubular structures like the esophagus and rectum. This 3D approach improves understanding of normal tissue response in cancer patients.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment Planning
Background:
- Spatial dose distribution is crucial for normal tissue response in tubular organs.
- Conventional dose-volume-histograms (DVHs) and dose-surface-histograms (DSHs) lack essential spatial information.
- Existing methods are inadequate for representing complex three-dimensional (3D) dose data in these structures.
Purpose of the Study:
- To introduce a novel 3D dose distribution data reduction scheme preserving longitudinal and circumferential characteristics.
- To develop a new tool for analyzing spatial dose distributions in tubular organs.
- To facilitate the study of normal tissue complication risks related to spatial dose patterns.
Main Methods:
- Generated dose distributions for esophagus and rectum in 123 lung and prostate cancer patients.
- Analyzed axial dose distribution histograms along the circumference to create dose-circumference-histogram (DCH) sheets.
- Developed two plot types from DCH sheets: percentage of circumference receiving dose, and minimum dose to a percentage of circumference.
Main Results:
- Successfully generated DCH sheets that retain longitudinal and circumferential dose information.
- Developed novel graphical representations of spatial dose distribution for tubular organs.
- Demonstrated the potential of DCHs as a treatment planning tool.
Conclusions:
- Dose-circumference-histograms (DCHs) offer a valuable method for representing 3D spatial dose data in tubular structures.
- DCHs can be integrated into 3D treatment planning systems.
- This approach is promising for investigating the relationship between spatial dose distribution and normal tissue complication risks.